| Dr Sherin Azmy, MD | |
|
703 Main St, Paterson, NJ 07503-2621 | |
| (973) 754-2000 | |
| Not Available |
| Full Name | Dr Sherin Azmy |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 22 Years |
| Location | 703 Main St, Paterson, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295069680 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jackson-madison County General Hospital | Jackson, TN | Hospital |
| North Kansas City Hospital | North kansas city, MO | Hospital |
| Hannibal Regional Hospital | Hannibal, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texans Anesthesia Associates Pllc | 8820171390 | 197 |
| Medical Center Anesthesia, Inc | 2769629187 | 86 |
| Hannibal Regional Healthcare System Inc | 1254236300 | 199 |
| Meritas Health Corporation | 6305748153 | 365 |
News Archive
Star Scientific announced today that it has completed a "Research and Royalty Agreement" with the Roskamp Institute's affiliate, SRQ Bio, LLC, under which the Institute will conduct research on a compound developed by the company's Rock Creek Pharmaceutical subsidiary that medical researchers at the Institute believe may have an application in the treatment of Alzheimer's disease.
Following the completion of its merger with Schering-Plough, Merck today confirms and underscores its commitment to marketing and developing cardiovascular medicines for a range of cardiovascular disorders.
While respiratory issues continue to be the most common symptom of a COVID-19 infection, new research indicates the disease could also be associated with hypercoagulability, or increased tendency of the blood to clot.
A team of researchers led by a biomedical scientist at the University of California, Riverside, has identified a novel mechanism by which loss-of-function mutations in the gene PTPN2, found in many patients with inflammatory bowel disease, or IBD, affect how intestinal epithelial cells maintain a barrier.
› Verified 5 days ago
| Entity Name | Texans Anesthesia Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275733982 PECOS PAC ID: 8820171390 Enrollment ID: O20080207000456 |
News Archive
Star Scientific announced today that it has completed a "Research and Royalty Agreement" with the Roskamp Institute's affiliate, SRQ Bio, LLC, under which the Institute will conduct research on a compound developed by the company's Rock Creek Pharmaceutical subsidiary that medical researchers at the Institute believe may have an application in the treatment of Alzheimer's disease.
Following the completion of its merger with Schering-Plough, Merck today confirms and underscores its commitment to marketing and developing cardiovascular medicines for a range of cardiovascular disorders.
While respiratory issues continue to be the most common symptom of a COVID-19 infection, new research indicates the disease could also be associated with hypercoagulability, or increased tendency of the blood to clot.
A team of researchers led by a biomedical scientist at the University of California, Riverside, has identified a novel mechanism by which loss-of-function mutations in the gene PTPN2, found in many patients with inflammatory bowel disease, or IBD, affect how intestinal epithelial cells maintain a barrier.
› Verified 5 days ago
| Entity Name | Emergenchealth Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467970897 PECOS PAC ID: 1355606641 Enrollment ID: O20180608000439 |
News Archive
Star Scientific announced today that it has completed a "Research and Royalty Agreement" with the Roskamp Institute's affiliate, SRQ Bio, LLC, under which the Institute will conduct research on a compound developed by the company's Rock Creek Pharmaceutical subsidiary that medical researchers at the Institute believe may have an application in the treatment of Alzheimer's disease.
Following the completion of its merger with Schering-Plough, Merck today confirms and underscores its commitment to marketing and developing cardiovascular medicines for a range of cardiovascular disorders.
While respiratory issues continue to be the most common symptom of a COVID-19 infection, new research indicates the disease could also be associated with hypercoagulability, or increased tendency of the blood to clot.
A team of researchers led by a biomedical scientist at the University of California, Riverside, has identified a novel mechanism by which loss-of-function mutations in the gene PTPN2, found in many patients with inflammatory bowel disease, or IBD, affect how intestinal epithelial cells maintain a barrier.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sherin Azmy, MD 703 Main St, Paterson, NJ 07503-2621 Ph: (973) 754-2000 | Dr Sherin Azmy, MD 703 Main St, Paterson, NJ 07503-2621 Ph: (973) 754-2000 |
News Archive
Star Scientific announced today that it has completed a "Research and Royalty Agreement" with the Roskamp Institute's affiliate, SRQ Bio, LLC, under which the Institute will conduct research on a compound developed by the company's Rock Creek Pharmaceutical subsidiary that medical researchers at the Institute believe may have an application in the treatment of Alzheimer's disease.
Following the completion of its merger with Schering-Plough, Merck today confirms and underscores its commitment to marketing and developing cardiovascular medicines for a range of cardiovascular disorders.
While respiratory issues continue to be the most common symptom of a COVID-19 infection, new research indicates the disease could also be associated with hypercoagulability, or increased tendency of the blood to clot.
A team of researchers led by a biomedical scientist at the University of California, Riverside, has identified a novel mechanism by which loss-of-function mutations in the gene PTPN2, found in many patients with inflammatory bowel disease, or IBD, affect how intestinal epithelial cells maintain a barrier.
› Verified 5 days ago
Dr. Gregory Bauman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 703 Main St, Department Of Anesthesiology, Paterson, NJ 07503 Phone: 973-754-2323 | |
Dr. Lars Michael Galldin, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 703 Main St, Paterson, NJ 07503 Phone: 973-754-2790 Fax: 973-754-2791 | |
Dr. Deborah Ames Bobila, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 703 Main St, Paterson, NJ 07503 Phone: 973-754-2000 | |
Dr. William R Ventura, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 703 Main Street, Paterson, NJ 07503 Phone: 973-754-2000 | |
Christina Marie Brown, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 703 Main St, Paterson, NJ 07503 Phone: 973-754-2000 | |
Marina Ezrokhi, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 703 Main St, Paterson, NJ 07503 Phone: 973-754-2323 Fax: 973-977-9455 | |
Jasmit Parihar, Anesthesiology Medicare: Medicare Enrolled Practice Location: 703 Main St, Paterson, NJ 07503 Phone: 973-754-2790 Fax: 973-754-2791 |